Bempedoic Acid in Statin-Intolerant Patients: Real-World Implementation Strategies, Cardiovascular Outcomes Beyond the CLEAR Trial, and Combination Therapy Approaches

Carlos Vergara Sanchez, Rodolfo A. Lopes, Michael D. Shapiro

Open source

DOI
10.1007/s11883-026-01483-3
Published
2026-11-05
Container
Current Atherosclerosis Reports
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11883-026-01483-3,
  title = {Bempedoic Acid in Statin-Intolerant Patients: Real-World Implementation Strategies, Cardiovascular Outcomes Beyond the CLEAR Trial, and Combination Therapy Approaches},
  author = {Carlos Vergara Sanchez and Rodolfo A. Lopes and Michael D. Shapiro},
  year = {2026},
  journal = {Current Atherosclerosis Reports},
  doi = {10.1007/s11883-026-01483-3},
  url = {https://doi.org/10.1007/s11883-026-01483-3}
}

RIS

TY  - JOUR
TI  - Bempedoic Acid in Statin-Intolerant Patients: Real-World Implementation Strategies, Cardiovascular Outcomes Beyond the CLEAR Trial, and Combination Therapy Approaches
AU  - Carlos Vergara Sanchez
AU  - Rodolfo A. Lopes
AU  - Michael D. Shapiro
PY  - 2026
JO  - Current Atherosclerosis Reports
DO  - 10.1007/s11883-026-01483-3
UR  - https://doi.org/10.1007/s11883-026-01483-3
ER  - 

APA

Sanchez, C. V., Lopes, R. A., & Shapiro, M. D. (2026). Bempedoic Acid in Statin-Intolerant Patients: Real-World Implementation Strategies, Cardiovascular Outcomes Beyond the CLEAR Trial, and Combination Therapy Approaches. Current Atherosclerosis Reports. https://doi.org/10.1007/s11883-026-01483-3

Source records